Investment bank GCA Savvian Corporation and financial advisory group Altium are to merge to form an independent international investment bank focused on growth companies with an extensive global network, cross-border capability and track record of industry-shaping transactions. The combined company will operate under the names GCA Altium in Europe and
Infrastructure investments have held up over the past five years but political and regulatory risk dominates investors’ lists of concerns according to the latest infrastructure investors survey from Deloitte, the business advisory firm. Deloitte surveyed 25 European infrastructure investors, including infrastructure funds and direct lenders, together holding over GBP200 billion
ACT Genomics, an integrated cancer molecular information company that transforms precision cancer care, has raised USD 12.5 million in Series B funding. Hotung Group, and CDIB Capital Management, led the round with continued participation from existing investors, Eminent II VC, Hua Nan Venture Capital, President International Development and UMC Capital
New research from BNY Mellon finds that private equity, real estate and infrastructure managers anticipate strong growth in assets in the next five years. The research, Building for the future: How alternative investment managers are rising to the demographic challenge, was prepared in collaboration with Preqin, finds that global macro-economic,
Humanyze, a specialist in people analytics technology, has secured USD4 million in Series A financing from Romulus Capital. The announcement comes as Humanyze rolls out the first of its kind Wyze people analytics platform to its strong Fortune 500 customer base in the US and industry leaders in Japan with
Ogier is acting as British Virgin Islands legal counsel to Atlantic Alliance Partnership Corp on its recently announced recommended offer for TLA Worldwide plc. TLA Worldwide plc (TLA) is a leading athlete representation, sports marketing and event management company which represents a number of prominent US and International sports stars,
venBio Partners has held the closing of the venBio Global Strategic Fund II, its second life sciences venture capital fund, for a total of approximately USD315 million, exceeding its target of USD250 million. venBio's Strategic Fund II is anchored by major investments from three strategic limited partners – Amgen, Merck,
Intervale Capital (Intervale), an energy-focused private equity firm, has made a growth equity investment in Dynacorp Energy Services (Dynacorp). Dynacorp provides innovative sand management solutions, well testing and production processing equipment to operators and service providers in the oil and gas industry. Justin Morin, Dynacorp's co-founder and Chief Executive
Attendees at this year’s Guernsey Funds Forum will have the opportunity to learn more about the proposed introduction of Guernsey’s new Manager Led Product (MLP). The MLP aims to ensure a proportionate risk-based level of product regulation for any Alternative Investment Fund Manager (AIFM) that establishes itself in Guernsey and
The latest New Zealand Private Equity and Venture Capital Monitor highlights an increase of investment in 2015 for both private equity and venture capital markets. Mid-market investment increased to NZD284.1 million from NZD243.5 million in 2014. The average deal value at NZD16.7 million was greater than the average of NZD12.8
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
